Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Analysis of Population Pharmacokinetic Data

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...

Dosage Regimen Designs: Nomograms and Tabulations

Dosage Regimen Designs: Nomograms and Tabulations

Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...

Dosage Regimen: Individualization

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...

Dosage Regimens: Partial Pharmacokinetic Parameters

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...

Dosage Regimens: Designs and Approaches

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cecal Duplication Cyst Presenting With Hematochezia.

ACG case reports journal·2025

Same author

Extra-adrenal Pheochromocytoma of the Urinary Bladder in an Adolescent Female Patient.

Cureus·2025

Same author

Mental Illness as a Predictor of Subjective Happiness Among University Employees Working in Hawai'i.

Journal of psychosocial nursing and mental health services·2023

Same author

Endovascular treatment of axillosubclavian arterial injuries is a safe alternative to open repair.

American journal of surgery·2022

Same author

Does autotransfusion from a contaminated trauma laparotomy field increase the risk of complications?

American journal of surgery·2021

Same author

Mortality in hypotensive trauma patients requiring laparotomy is related to degree of hypotension and provides evidence for focused interventions.

Trauma surgery & acute care open·2021

Search research articles

Related Experiment Video

Updated: May 7, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Using quantile regression to assess disparities in medication adherence.

Deborah T Juarez¹, Candace Tan, James W Davis

¹College of Pharmacy, University of Hawaii, Hilo, HI, USA. dtjuarez@hawaii.edu.

American Journal of Health Behavior

|September 17, 2013

Summary

Racial and ethnic disparities in medication adherence persist among Asian and Pacific Islander Americans compared to Whites. Significant gaps, especially in lipid-lowering medications, highlight critical healthcare inequities.

More Related Videos

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples

Published on: May 19, 2020

Related Experiment Videos

Last Updated: May 7, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples

Published on: May 19, 2020

Area of Science:

Health Services Research
Health Disparities
Pharmacoeconomics

Background:

Medication adherence is crucial for managing chronic conditions like diabetes.
Understanding racial and ethnic disparities in adherence is vital for equitable healthcare.
Previous research indicates varying adherence rates across different demographic groups.

Purpose of the Study:

To investigate racial and ethnic disparities in medication adherence.
To compare adherence rates between Asian and Pacific Islander Americans and White populations.
To identify specific medication classes where disparities are most pronounced.

Main Methods:

Retrospective data analysis of 43,445 diabetes patients in Hawaii.
Quantile regression analysis (25th, 50th, 75th quantiles) for anti-diabetic, lipid-lowering, and anti-hypertensive medications.
Controlled for patient characteristics to isolate the association with race and ethnicity.

Main Results:

Filipinos, Native Hawaiians, and other Pacific Islanders demonstrated significantly lower medication adherence than Whites.
The most substantial disparities were observed in lipid-lowering medication adherence among other Pacific Islanders.
Adjusted analyses showed adherence reductions of up to 19% for lipid-lowering medications in the 25th quantile for other Pacific Islanders compared to Whites.

Conclusions:

Significant medication adherence disparities exist for Filipinos, Native Hawaiians, and other Pacific Islanders.
These disparities are substantial and require targeted interventions.
The greatest gaps at lower adherence quantiles suggest heightened vulnerability and potential access-to-care issues among these populations.